Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026)

Caris Life Sciences' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $49000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 388.24% year-over-year to $49000.0; the TTM figure through Mar 2026 stood at -$20.5 million (down 13841.5% YoY), while the FY2025 annual figure was -$20.6 million, down 5791.12% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $49000.0, up from -$2.1 million in the prior quarter.
• The five-year high for Other Non Operating Income was $49000.0 in Q1 2026, with the low at -$18.3 million in Q2 2025.
• The 3-year median for Other Non Operating Income is -$57500.0 (2024), against an average of -$2.6 million.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income slumped 12907.8% in 2025, then jumped 388.24% in 2026.
• Caris Life Sciences' Other Non Operating Income stood at -$26000.0 in 2024, then sank by 8026.92% to -$2.1 million in 2025, then soared by 102.32% to $49000.0 in 2026.
• Business Quant data shows CAI's Other Non Operating Income at $49000.0 in Q1 2026, -$2.1 million in Q4 2025, and -$89000.0 in Q3 2025.